| RELATED PARTY |
NOTE 20 – RELATED PARTY The details of transactions with the related parties for the six months ended June 30, 2026 and 2025 and balances outstanding as on June 30, 2026 and December 31, 2025 are as follows: | Particulars | | For the period ended June 30, 2026 | | | For the period ended June 30, 2025 | | | Transactions during the period: | | | | | | | | | | | | | | | | Expenses incurred on behalf of affiliates | | | | | | | | | | Srivastava Robotic Surgery Pvt Ltd | | $ | 333 | | | $ | 68 | | | SS International Centre for Robotics Surgery Pvt Ltd | | | 4,788 | | | | 9.906 | | | Sudhir Srivastava Medical Innovations Pvt Ltd | | | 410 | | | | 92 | | | Telegnosis Pvt Ltd | | | 70 | | | | 8 | | | Sudhir Prem Srivastava, M.D. | | | - | | | | 18,000 | | | | | | | | | | | | | Expense incurred on behalf of Company | | | | | | | | | | Sudhir Prem Srivastava, M.D. | | | 63,826 | | | | 123,476 | | | Barry F. Cohen | | | - | | | | 5,753 | | | Dr. Frederic H Moll | | | - | | | | 11,499 | | | Milan Rao# | | | 4,216 | | | | - | | | Dr. S.P. Somashekhar | | | 510 | | | | - | | | Mr. Tim Adams | | | 1,867 | | | | - | | | | | | | | | | | | | 2016 Stock Incentive Plans Expenses/(Reversal) | | | | | | | | | | Anup Sethi | | | - | | | | (122,247 | ) | | Barry F. Cohen | | | 285,977 | | | | 285,977 | | | Dr. S.P. Somashekhar | | | 106,197 | | | | 105,266 | | | Sudhir Prem Srivastava, M.D. | | | 857,931 | | | | 857,931 | | | Vishwajyoti P. Srivastava, M.D | | | 285,977 | | | | 285,977 | | | Milan Rao# | | | 170,150 | | | | - | | | | | | | | | | | | | Consultancy charges and other perquisites | | | | | | | | | | Anup Sethi | | | - | | | | 68,149 | | | Barry F. Cohen | | | 90,000 | | | | 90,000 | | | Sudhir Prem Srivastava, M.D. | | | 480,799 | | | | 441,200 | | | Vishwajyoti P. Srivastava, M.D | | | 196,396 | | | | 129,908 | | | Arvind Palaniappan | | | - | | | | 12,160 | | | Milan Rao# | | | 140,002 | | | | - | | | Dr. Frederic H Moll | | | 4,500 | | | | - | | | Dr. S.P. Somashekhar | | | 4,500 | | | | - | | | Mr. Tim Adams | | | 4,500 | | | | - | | | Mylswamy Annadurai | | | 4,500 | | | | - | | | | | | | | | | | | | Proceeds from Private Investment in Public Equity | | | | | | | | | | Sushruta Private Limited | | | 2,000,000 | | | | - | | | Mr. Tim Adams | | | 1,197,000 | | | | - | | | Dr. Frederic H Moll | | | 2,000,000 | | | | - | | | | | | | | | | | | | Proceeds from notes issued | | | | | | | | | | Sushruta Private Limited | | | - | | | | 28,000,000 | | | | | | | | | | | | | Interest accrued on notes | | | | | | | | | | Sushruta Private Limited | | | - | | | | 182,400 | | | | | | | | | | | | | Conversion of notes into common stock | | | | | | | | | | Sushruta Private Limited | | $ | - | | | $ | 30,164,548 | | Balance outstanding as of period end: | Accrued expenses & other current liabilities: | | As of June 30, 2026 | | | As of December 31, 2025 | | | | | | | | | | | Balance payable | | | | | | | | | | Barry F. Cohen | | $ | (580,500 | ) | | $ | (496,253 | ) | | | | | | | | | | | | Prepaids and other current assets: | | | | | | | | | | Srivastava Robotic Surgery Pvt Ltd | | | 699 | | | | 394 | | | SS International Centre for Robotics Surgery Pvt Ltd | | | 21,170 | | | | 17,360 | | | Cardio Bahamas^ | | | (76,741 | ) | | | (76,741 | ) | | SSI PTE Singapore^ | | | (424,586 | ) | | | (424,586 | ) | | Sudhir Prem Srivastava, M.D.^ | | | 2,199,657 | | | | 2,378,493 | | | Sudhir Srivastava Medical Innovations Pvt Ltd | | | 928 | | | | 556 | | | Telegnosis Private Limited | | | 1,263 | | | | 1,257 | | | Sushruta Private Limited | | | 5.000 | | | | 5,000 | | | Vishwajyoti P. Srivastava, M.D | | $ | - | | | $ | 10,178 | | | ^ | For these balances, Dr. Sudhir Prem Srivastava is considered as the ultimate beneficial owner, and the settlement is expected to be made on net basis. Accordingly, these balances have been disclosed under prepaids and other current assets. | | # | During the current period, Mr. Naveen Kumar Amar resigned from the position of Chief Financial Officer effective January 2, 2026. Thereafter, on January 16, 2026, the Company appointed Milan Rao as Global Chief Operating Officer and Chief Financial Officer. Mr. Millan Rao subsequently resigned from his position as Chief Financial Officer, effective May 25, 2026. Subsequently, on August 3, 2026, the Company appointed Sarah M. Romano as Chief Financial Officer. |
|